Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.
Yoshimi A, Mohamed M, Bierings M, Urban C, Korthof E, Zecca M, Sykora KW, Duffner U, Trebo M, Matthes-Martin S, Sedlacek P, Klingebiel T, Lang P, Führer M, Claviez A, Wössmann W, Pession A, Arvidson J, O'Marcaigh AS, van den Heuvel-Eibrink MM, Starý J, Hasle H, Nöllke P, Locatelli F, Niemeyer CM.
Yoshimi A, et al. Among authors: zecca m.
Leukemia. 2007 Mar;21(3):556-60. doi: 10.1038/sj.leu.2404537. Epub 2007 Feb 1.
Leukemia. 2007.
PMID: 17268527
Clinical Trial.
No abstract available.